Abstract

CABRERA-PAYNE, Yusselys et al. G20210a mutation of the prothrombin gene: clinical presentation in two pregnant women. Rev Cubana Hematol Inmunol Hemoter [online]. 2015, vol.31, n.4, pp. 0-0. ISSN 1561-2996.

Hereditary thrombophilia is a genetic disease that results from two or more mutations in genes involved in the hemostatic system, with variable penetrance of the thrombotic phenotype. Among the mutated genes associated with increased risk of venous thrombosis is mutation G20210A prothrombin gene. We present two pregnant young patients who attended the Haemostasis outpatient service at the Institute of Hematology and Immunology. One of them, with personal history of thromboembolic disease (TED) associated with use of oral contraceptives; and the other one, with a family history of TED and personal history of recurrent abortions. In both patients´ thrombophilia studies the G20210A mutation in the prothrombin gene in heterozygous state was detected. The patients received multidisciplinary medical monitoring and prophylactic treatment with low-dose aspirin until week 34 of gestation, and low molecular weight heparin during pregnancy and six weeks after delivery. Two births without obstetric or fetal complications were achieved. The gene expression of prothrombin G20210A is variable, even within the same family and may be influenced by acquired risk factors such as the use of oral contraceptives, pregnancy and the postpartum period.

Keywords : G20210A mutation of the prothrombin gene; inherited thrombophilia; pregnancy.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )